Laparoscopic Repair of Ventral and other hernias of the abdominal wall with Composite meshes (Ventralight ST with Echo PS System and Physiomesh): Our case series of 101 patients and the literature

• Published in: International journal of surgery case reports 2020-01, Vol.77 (Suppl), p.S40-S43
• Main Authors: Bono, Dario, Di Ciero, Marco, Arnone, Giovanni, Tomaselli, Francesco, Saracco, Roberto
• Format: Article
• Language: English
• Subjects: Case Series; Laparoscopic ventral hernia repair; Physiomesh; Secure strap; Sorbafix; Ventralight ST
• ISSN: 2210-2612; 2210-2612
• DOI: 10.1016/j.ijscr.2020.08.064

•The incidence of ventral hernias varies from 4 to 10% depending on the type of surgery.•Careful patient selection is one of the main methods of choice.•Laparoscopic ventral hernia repair with Ventralight ST/Sorbafix is a safe and effective technique with low postoperative morbidity and low reoperation rate. A meta-analysis of studies has shown that the incidence of ventral hernias varies from 4 to 10%. During the last twenty years, the use of laparoscopic repair of ventral and other hernias of the abdominal wall has rapidly increased. From January 2011 to March 2020 101 patients underwent laparoscopic ventral hernia repair (LVHR). The diameter of the hernial defect intraoperatively was in average 6.22 ± 5.17 cm (SD) (range 2–30 cm). The difference with the defect diameter measured in CT is small (average 0.77 ± 2.21 cm). The mean operative time was 96.20 min. We used Physiomesh and Secure strap in 37 cases and Ventralight ST plus Sorbafix in 58 cases. The conversion rate was 6.93%. The mean hospital stay was 6.03 days. The 30-day mortality was 0%. The overall morbidity was 11.88%. LVHR indications are debated. The IEHS guidelines and the EAES/EHS Consensus conference of 2015 discussed the main indications, contraindications, and features of laparoscopic techniques. Laparoscopic approach seemed to have some benefits: absence of intraparietal dissection, of postoperative immobilization, lower risk of bronchopulmonary complications and lesser abdominal pain. We compared our case series with other similar studies, and we revealed our short-term outcomes are in line with literature. Our case series revealed that the LVHR with Ventralight ST/Sorbafix is a safe and effective technique with low postoperative morbidity and low reoperation rate. Careful patient selection is one of the main methods of choice. Studies with higher level of evidence are needed.